Ascend Wellness Holdings (AAWH) Receivables (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Receivables of $26.4 million for Q1 2026, down 28.83% year-over-year from $37.1 million in Q1 2025, and down 13.92% quarter-over-quarter from $30.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Receivables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Receivables history runs 7 years deep, the most recent figure standing at $26.4 million for Q1 2026.
- In Q1 2026, Receivables fell 28.83% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $26.4 million (down 28.83% YoY), while the FY2025 annual figure was $30.7 million, down 24.0% from the prior year.
- Receivables for Q1 2026 stood at $26.4 million, down from $30.7 million in the prior quarter.
- The five-year high for Receivables was $40.4 million in Q4 2024, with the low at $9.3 million in Q2 2022.
- The 5-year median for Receivables is $28.5 million (2023), against an average of $26.4 million.
- The sharpest annual moves came in 2023 and 2026: Receivables soared 138.85% in 2023, then declined 28.83% in 2026.
- Ascend Wellness Holdings' Receivables stood at $14.3 million in 2022, then soared by 99.58% to $28.5 million in 2023, then soared by 41.88% to $40.4 million in 2024, then fell by 24.0% to $30.7 million in 2025, then retreated by 13.92% to $26.4 million in 2026.
- Business Quant data shows AAWH's Receivables at $26.4 million in Q1 2026, $30.7 million in Q4 2025, and $29.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.08 Bn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 26.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.26 Mn |
| Mar 31, 2026 | 26.42 Mn |
| Dec 31, 2025 | 30.70 Mn |
| Sep 30, 2025 | 29.03 Mn |
| Jun 30, 2025 | 30.82 Mn |
| Mar 31, 2025 | 37.12 Mn |
| Dec 31, 2024 | 40.39 Mn |
| Sep 30, 2024 | 38.95 Mn |
| Jun 30, 2024 | 35.49 Mn |
| Mar 31, 2024 | 36.07 Mn |
| Dec 31, 2023 | 28.47 Mn |
| Sep 30, 2023 | 25.55 Mn |
| Jun 30, 2023 | 22.29 Mn |
| Mar 31, 2023 | 19.64 Mn |
| Dec 31, 2022 | 14.26 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 9.33 Mn |
| Mar 31, 2022 | 10.53 Mn |
| Dec 31, 2021 | 7.77 Mn |
| Sep 30, 2021 | 12.95 Mn |